期刊文献+

p73变异体研究现状及其在肿瘤放疗中的应用前景

Progress on p73 Variant and Its Possible Application in Tumor Radiotherapy
原文传递
导出
摘要 p73基因是p53抑癌基因家族的新成员。p73有两组蛋白异构体:TAp73和DNp73。TAp73具有诱导细胞周期停滞和细胞凋亡的能力,而DNp73却有与之相反的能力,具有肿瘤促进作用。对p73基因两面性的特点及研究进展作一综述。最后结合重离子治疗肿瘤,探讨了p73联合重离子治疗的新思路。 p73 was the first identified homologue of the tumor suppressor gene, p53. p73 has two groups of protein isoforms: TAp73 and DNp73. TAp73 can induce cell cycle arrest, resulting in the ability of apoptosis, however DNp73 has antagonistic property of a tumor promoting effect. In this paper, the dual roles of p73 gene and its research progress was reviewed. Finally, combined with heavy ion treatment of tumor, we explored some new ideas of p73-heavy ion joint therapy.
出处 《原子核物理评论》 CAS CSCD 北大核心 2012年第1期103-108,共6页 Nuclear Physics Review
基金 国家重点基础研究发展计划项目(973计划)(2010CB834202) 国家自然科学基金重点项目(10835011)~~
关键词 p73变异体 选择性剪接 肿瘤 细胞凋亡 p73 variant alternative splicing tumor apoptosis
  • 相关文献

参考文献38

  • 1JOST C A,MARIN M C,KAELIN W G.Jr Nature,1997,389(6647):191.
  • 2KAGHAD M,BONNET H,YANG A,et al.Cell,1997,90(4):809.
  • 3OSWALD C,STIEWE T.Cell Cycle,2008,7(12):1726.
  • 4DAVID C J,MANLEY J L.Genes Dev,2010,24(21):2343.
  • 5LUCO R F,ALLO M,SCHOR I E,et al.Cell,2011,144(1):16.
  • 6YANG Y,ZHAN L,ZHANG W,et al.Nat Struct Mol Biol,2011,18(2):159.
  • 7COATES P J.J Pathol,2006,210(4):385.
  • 8MEYN R E,MILAS L,ANG K K.Int J Radiat Biol,2009,85(2):107.
  • 9SREBROW A,KORNBLIHTT A R.J Cell Sci,2006,119(13):2635.
  • 10VILGELM A E,HONG S M,WASHINGTON M K,et al.Oncogene,2011,29(43):5861.

二级参考文献56

  • 1戴中颖,李强,闫铮,金晓东,胡正国,肖国青.HIRFL浅层肿瘤治疗终端治癌碳离子束物理特性的测量[J].高能物理与核物理,2006,30(9):920-924. 被引量:7
  • 2[10]Yang A, Kaghad M, Wang Y, et al. p63,a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities [J]. Mol Cell,1998,2:305- 316.
  • 3[11]Osada M, Ohba M, Kawahara C, et al. Cloning and functional analysis of human p51, which structurally and functionally resembles p53 [J]. Nat,Med,1998,4:839- 843.
  • 4[12]Kaelin WG Jr. The emerging p53 gene family [J]. J Natl Cancer Inst, 1999, 91(7):594- 598.
  • 5[13]Strano S, Rossi M, Fontemaggi G, et al. From p63 to p53 across p73 [J]. FEBS Lett, 2001, 490(3):163- 170.
  • 6[14]Lohrum MA, Vousden KH. Regulation and function of the p53-related proteins: same family,different rules [J]. Trends Cell Biol, 2000, 10(5):197- 202.
  • 7[15]Calabro V, Mansueto G, Parisi T, et al. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53-homologue p63 [J]. J Biol Chem,2001,277: 2674- 2681.
  • 8[16]Grossman SR, Perez M, Kung AL, et al. p300/MDM2 complexes participate in MDM2-mediated p53 degradation [J]. Molecular Cell,1998, 2:405- 415.
  • 9[17]Bruce C, Mark G. Tumor suppressor genes, killer in search of a motive? [J]. Nature, 1997, 389: 122- 123.
  • 10[18]Sherr CJ. Tumor suveillance via the ARF-p53 pathway [J]. Gene, 1998, 12:2984- 2991.

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部